Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study.

Autor: Olmo-Montes FJ; Internal Medicine Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain., Caeiro-Rey JR; Traumatology Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Peris P; Rheumatology Department, Hospital Clinic de Barcelona, Barcelona, Spain., Pérez Del Río V; Traumatology Department, Hospital San Juan de la Cruz, Úbeda, Spain.; Medicine and Dermatology Department, Faculty of Medicine of Universidad de Málaga, Málaga, Spain., Etxebarria-Foronda Í; Traumatology Department, Hospital Alto Deba, Gipuzkoa, Spain., Cancio-Trujillo JM; Geriatrics Department, Badalona Serveis Assistencials, Badalona, Spain., Pareja T; Geriatrics Department, Hospital Universitario de Guadalajara, Guadalajara, Spain., Jódar E; Endocrinology Department, Hospital Universitario Quirón de Madrid, Madrid, Spain., Naranjo A; Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Moro-Álvarez MJ; Internal Medicine Department, Hospital Central Universitario Cruz Roja 'San Jose y Santa Adela', Madrid, Spain., García-Goñi M; Department of Applied & Structural Economics and History, Faculty of Economics and Business, Universidad Complutense de Madrid, Madrid, Spain., Vergés J; Asociación Española con la Osteoporosis y la Artrosis (AECOSAR), Madrid, Spain., Maratia S; UCB Pharma S.A., Madrid, Spain., Campos Tapias I; Amgen S.A., Barcelona, Spain., Prades M; Outcomes'10, S.L.U., Castellón de la Plana, Spain., Aceituno S; Outcomes'10, S.L.U., Castellón de la Plana, Spain.

Publikováno v: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2024 Dec 24; Vol. 16, pp. 889-901. Date of Electronic Publication: 2024 Dec 24 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain, and the United Kingdom.

Autor: Tai MH; a Amgen Inc , Thousand Oaks , CA , USA., Shepherd J; b Adelphi Real World , Macclesfield , UK., Bailey H; b Adelphi Real World , Macclesfield , UK., Williams N; b Adelphi Real World , Macclesfield , UK., Hatz M; c Amgen GmbH , Munich , Germany., Campos Tapias I; d Amgen SA , Barcelona , Spain., Catterick D; e Amgen UK , Uxbridge , UK., Worth G; f Amgen (Europe) GmbH , Zug , Switzerland.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2019 May; Vol. 35 (5), pp. 829-835. Date of Electronic Publication: 2018 Nov 20.

The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: A Comparison Between the use of Denosumab and Zoledronic acid in Patients With Breast Cancer and Bone Metastases

Autor: Cristino, J, Diel, I, Finek, J, Perez Encinas, M, Maniadakis, N, Ikenberg, R, Campos Tapias, I, Jandova, P, Zahn, DP, Moser, C, Bolognese, L, Tritaki, G, Gatta, F, Hechmati, G

Publikováno v: Value in Health. 18:A483

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63371c5247e3d48ad9337b4e3dd8eec6
https://doi.org/10.1016/j.jval.2015.09.1318

PCN299 - The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: A Comparison Between the use of Denosumab and Zoledronic acid in Patients With Breast Cancer and Bone Metastases

Autor: Cristino, J, Diel, I, Finek, J, Perez Encinas, M, Maniadakis, N, Ikenberg, R, Campos Tapias, I, Jandova, P, Zahn, DP, Moser, C, Bolognese, L, Tritaki, G, Gatta, F, Hechmati, G

Publikováno v: In Value in Health November 2015 18(7):A483-A483